These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 32919684)
1. Synthesis, chemical and biochemical characterization of Lu Ancira-Cortez A; Ferro-Flores G; Jiménez-Mancilla N; Morales-Avila E; Trujillo-Benítez D; Ocampo-García B; Santos-Cuevas C; Escudero-Castellanos A; Luna-Gutiérrez M Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111335. PubMed ID: 32919684 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biochemical Evaluation of Samarium-153 Oxide Nanoparticles Functionalized with iPSMA-Bombesin Heterodimeric Peptide. Trujillo-Benítez D; Ferro-Flores G; Morales-Avila E; Jiménez-Mancilla N; Ancira-Cortez A; Ocampo-García B; Santos-Cuevas C; Escudero-Castellanos A; Luna-Gutiérrez M; Azorín-Vega E J Biomed Nanotechnol; 2020 May; 16(5):689-701. PubMed ID: 32919488 [TBL] [Abstract][Full Text] [Related]
10. Influence of Eu(3+) doping content on antioxidant properties of Lu2O3 sol-gel derived nanoparticles. Olvera Salazar A; García Hernández M; López Camacho PY; López Marure A; Reyes de la Torre AI; Morales Ramírez Áde J; Hernández Santiago F; Aguilera Vázquez L Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():850-5. PubMed ID: 27612779 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer. Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the radiation absorbed dose produced by Azorín-Vega E; Rojas-Calderón E; Ferro-Flores G; Aranda-Lara L; Jiménez-Mancilla N; Nava-Cabrera MA Appl Radiat Isot; 2019 Apr; 146():66-71. PubMed ID: 30753987 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer. Schottelius M; Wurzer A; Wissmiller K; Beck R; Koch M; Gorpas D; Notni J; Buckle T; van Oosterom MN; Steiger K; Ntziachristos V; Schwaiger M; van Leeuwen FWB; Wester HJ J Nucl Med; 2019 Jan; 60(1):71-78. PubMed ID: 30237214 [TBL] [Abstract][Full Text] [Related]
15. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418 [TBL] [Abstract][Full Text] [Related]
16. Head to head comparison performance of García-Pérez FO; Davanzo J; López-Buenrostro S; Santos-Cuevas C; Ferro-Flores G; Jímenez-Ríos MA; Scavuzzo A; Santana-Ríos Z; Medina-Ornelas S Am J Nucl Med Mol Imaging; 2018; 8(5):332-340. PubMed ID: 30510850 [TBL] [Abstract][Full Text] [Related]
17. Comparison between Nava-Cabrera M; Azorín-Vega E; Oros-Pantoja R; Aranda-Lara L Appl Radiat Isot; 2021 Oct; 176():109898. PubMed ID: 34418726 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer. Lesniak WG; Boinapally S; Banerjee SR; Behnam Azad B; Foss CA; Shen C; Lisok A; Wharram B; Nimmagadda S; Pomper MG Mol Pharm; 2019 Jun; 16(6):2590-2604. PubMed ID: 31002252 [TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
20. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. Umbricht CA; Benešová M; Schibli R; Müller C Mol Pharm; 2018 Jun; 15(6):2297-2306. PubMed ID: 29684274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]